However, there is some evidence to suggest that previous TNF antagonist therapy in patients with rheumatoid arthritis is associated with serious infection,25 and switching from a TNF antagonist to a treatment with an alternative mechanism of action may reduce the risks of infection.32 An explanation for these observations is not readily apparent. The gene discussed is TNF; the disease is infection.